NovoCure Ltd Quarterly Return On Equity in % from Q2 2016 to Q3 2024
-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
NovoCure Ltd quarterly/annual Return On Equity history and growth rate from Q2 2016 to Q3 2024.
- NovoCure Ltd Return On Equity for the quarter ending September 30, 2024 was -41.5 %, a 11.5% increase year-over-year.
- NovoCure Ltd annual Return On Equity for 2023 was -51.6 %, a 146% decline from 2022.
- NovoCure Ltd annual Return On Equity for 2022 was -21 %, a 43.2% decline from 2021.
- NovoCure Ltd annual Return On Equity for 2021 was -14.7 %, a 339% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)